For: | You MS, Ryu JK, Huh G, Chun JW, Paik WH, Lee SH, Kim YT. Comparison of efficacy between adjuvant chemotherapy and chemoradiation therapy for pancreatic cancer: AJCC stage-based approach. World J Clin Oncol 2020; 11(9): 747-760 [PMID: 33033696 DOI: 10.5306/wjco.v11.i9.747] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v11/i9/747.htm |
Number | Citing Articles |
1 |
Anthony Turpin, Mehdi el Amrani, Jean-Baptiste Bachet, Daniel Pietrasz, Lilian Schwarz, Pascal Hammel. Adjuvant Pancreatic Cancer Management: Towards New Perspectives in 2021. Cancers 2020; 12(12): 3866 doi: 10.3390/cancers12123866
|
2 |
Valeria Tonini, Manuel Zanni. Pancreatic cancer in 2021: What you need to know to win. World Journal of Gastroenterology 2021; 27(35): 5851-5889 doi: 10.3748/wjg.v27.i35.5851
|
3 |
Manish Manrai, T V S V G K Tilak, Saurabh Dawra, Sharad Srivastava, Anupam Singh. Current and emerging therapeutic strategies in pancreatic cancer: Challenges and opportunities. World Journal of Gastroenterology 2021; 27(39): 6572-6589 doi: 10.3748/wjg.v27.i39.6572
|
4 |
媛媛 苏. Effects of Radiotherapy and Chemotherapy on Postoperative Prognosis of Patients Undergoing Radical Surgery for Pancreatic Cancer—Based on SEER Database Analysis. Advances in Clinical Medicine 2022; 12(10): 9540 doi: 10.12677/ACM.2022.12101380
|
5 |
Ashu Shah, Koelina Ganguly, Sanchita Rauth, Shamema S. Sheree, Imran Khan, Apar K. Ganti, Moorthy P. Ponnusamy, Sushil Kumar, Maneesh Jain, Surinder K. Batra. Unveiling the resistance to therapies in pancreatic ductal adenocarcinoma. Drug Resistance Updates 2024; 77: 101146 doi: 10.1016/j.drup.2024.101146
|
6 |
Bo Li, Shuo Shen, Siting You, Guoxiao Zhang, Suizhi Gao, Xiaohan Shi, Huan Wang, Xiaoyi Yin, Xiongfei Xu, Shiwei Guo, Gang Jin. Comparison of 4- and 4 plus-courses S-1 administration as adjuvant chemotherapy for pancreatic ductal adenocarcinoma. BMC Cancer 2021; 21(1) doi: 10.1186/s12885-021-08380-9
|